FDA Approves Sirolimus Balloon for Stent Reblockage
The Selution SLR drug-eluting balloon is the first sirolimus-based device of its kind cleared in the US for coronary in-stent restenosis.
Medicine & Biotech
Clinical AI, drug discovery, devices, and regulatory approvals.
Rare Pregnancy Infections Linked to Autism and Intellectual Disability
A Karolinska Institutet study in JAMA Pediatrics finds that rare fetal infections are associated with higher risks of autism and intellectual disability.
Trump's New Vaccine Demands Echo Old Misinformation, STAT Reports
President Trump's latest vaccine-related demands repeat previously debunked claims, according to STAT.
Novo Nordisk seeks to reassure investors with new drug pipeline
At a capital markets day, Novo's CEO acknowledged investor doubts and outlined plans to compete with Eli Lilly and launch several multibillion-dollar products.
Telix to Buy ITM for $1.65B, Challenging Novartis in Radiopharma
The acquisition gives Telix a late-stage pipeline and supply network that could compete with Novartis' Lutathera.
Alkermes orexin agonist shows early promise for ADHD
Early-stage data suggest Alkermes' orexin agonist could expand the drug class beyond sleep disorders into ADHD.
Beacon Gene Therapy for Rare Vision Loss Succeeds in Pivotal Trial
A pivotal trial of Beacon Therapeutics' gene therapy for X-linked retinitis pigmentosa improved visual acuity, clearing the path toward an FDA submission.
Novo Nordisk Cuts 4,000 More Jobs; Sionna Halves Staff
The new layoff tracker shows major biotech employers still shedding staff in 2026, with Novo Nordisk making deep cuts and Sionna dramatically reducing headcount.
Ebola Vaccine Trial Launches in DR Congo Outbreak Zone
Health workers in DR Congo have begun testing whether a vaccine designed for a different Ebola strain can protect against the current outbreak.
Most sports parents see net benefits in youth sports, survey finds
A new survey shows parents overwhelmingly believe the advantages of organized youth sports outweigh the harms for both themselves and their children.
All 50 States Apply for New Medicaid Drug Pricing Model
The Trump administration's plan to bring most-favored-nation pricing to Medicaid has drawn participation requests from every state, according to the White House.
J&J's Caplyta clears phase 3 for bipolar mania, widening label path
A positive phase 3 result moves Caplyta closer to approval for bipolar manic episodes, building on its blockbuster sales and J&J's $14.6 billion acquisition.
Personalized Fall Prevention Programs May Not Reduce Falls
A comprehensive research review suggests that tailored fall-prevention programs for older adults do not reduce how often falls occur.
Activated Donor T Cells Aim to Prevent GvHD After Stem Cell Transplant
First clinical trial tests activated regulatory T cells from healthy donors to prevent graft-versus-host disease in stem cell transplant patients.
Study Links Eight Common Food Additives to Hypertension Risk
A new report identifies widely used preservatives associated with higher rates of high blood pressure and heart disease.
Study: One-third of older adults with cognitive disorders take risky CNS drugs
A new analysis finds that many seniors with dementia or other cognitive conditions are prescribed medications that can worsen their health and lead to emergency visits.
ARPA-H Launches SPECTRA Program to Tackle Autism Research Gaps
The new initiative aims to build an end-to-end system linking autism risk-factor identification, patient interventions, and clinical research.
Veteran Advocate Urges FDA to Consider Psychedelics for Mental Health
A Marine Corps veteran and advocate pressed the FDA to consider psychedelic treatments for severe mental health conditions, as reported by MedPage Today.